MEDIROM HEALTHCARE TECHNOLOG (MRM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MRM • US58510H1032

1.48 USD
-0.05 (-3.27%)
At close: Jan 30, 2026
1.4699 USD
-0.01 (-0.68%)
After Hours: 1/30/2026, 8:07:18 PM
Fundamental Rating

2

Taking everything into account, MRM scores 2 out of 10 in our fundamental rating. MRM was compared to 76 industry peers in the Diversified Consumer Services industry. MRM may be in some trouble as it scores bad on both profitability and health. MRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MRM has reported negative net income.
  • MRM had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MRM reported negative net income in multiple years.
  • In the past 5 years MRM always reported negative operating cash flow.
MRM Yearly Net Income VS EBIT VS OCF VS FCFMRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

  • With a Return On Assets value of 1.84%, MRM perfoms like the industry average, outperforming 55.26% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.94%, MRM is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 0.09%, MRM is in line with its industry, outperforming 48.68% of the companies in the same industry.
Industry RankSector Rank
ROA 1.84%
ROE 15.94%
ROIC 0.09%
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRM Yearly ROA, ROE, ROICMRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • MRM's Profit Margin of 1.79% is in line compared to the rest of the industry. MRM outperforms 51.32% of its industry peers.
  • In the last couple of years the Profit Margin of MRM has grown nicely.
  • Looking at the Operating Margin, with a value of 0.06%, MRM is in line with its industry, outperforming 47.37% of the companies in the same industry.
  • MRM's Operating Margin has declined in the last couple of years.
  • MRM has a Gross Margin of 27.07%. This is in the lower half of the industry: MRM underperforms 67.11% of its industry peers.
  • In the last couple of years the Gross Margin of MRM has grown nicely.
Industry RankSector Rank
OM 0.06%
PM (TTM) 1.79%
GM 27.07%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
MRM Yearly Profit, Operating, Gross MarginsMRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

0

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRM is destroying value.
  • MRM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MRM has more shares outstanding
  • MRM has a worse debt/assets ratio than last year.
MRM Yearly Shares OutstandingMRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MRM Yearly Total Debt VS Total AssetsMRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • MRM has an Altman-Z score of 1.00. This is a bad value and indicates that MRM is not financially healthy and even has some risk of bankruptcy.
  • MRM has a Altman-Z score (1.00) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that MRM has dependencies on debt financing.
  • MRM has a Debt to Equity ratio of 1.35. This is in the lower half of the industry: MRM underperforms 65.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.04
WACC2.27%
MRM Yearly LT Debt VS Equity VS FCFMRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

  • MRM has a Current Ratio of 0.65. This is a bad value and indicates that MRM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRM has a Current ratio of 0.65. This is in the lower half of the industry: MRM underperforms 77.63% of its industry peers.
  • MRM has a Quick Ratio of 0.65. This is a bad value and indicates that MRM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, MRM is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.61
MRM Yearly Current Assets VS Current LiabilitesMRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

  • MRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -180.69%.
  • Measured over the past years, MRM shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.92% on average per year.
  • MRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.55%.
  • Measured over the past years, MRM shows a quite strong growth in Revenue. The Revenue has been growing by 16.25% on average per year.
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRM Yearly Revenue VS EstimatesMRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

4. Valuation

4.1 Price/Earnings Ratio

  • MRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRM Price Earnings VS Forward Price EarningsMRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • MRM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MRM is cheaper than 61.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.81
MRM Per share dataMRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • MRM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MEDIROM HEALTHCARE TECHNOLOG / MRM FAQ

What is the ChartMill fundamental rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MRM.


What is the valuation status of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDIROM HEALTHCARE TECHNOLOG (MRM). This can be considered as Overvalued.


How profitable is MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

MEDIROM HEALTHCARE TECHNOLOG (MRM) has a profitability rating of 3 / 10.